Metastatic Renal Cell Carcinoma Risk According to Tumor Size

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 41-45

  Thompson, R Houston ^a   Hill, Jennifer R ^a   Babayev, Yuriy ^a   Cronin, Angel ^a   Kaag, Matt ^a   Kundu, Shilajit ^a   Bernstein, Melanie ^a   Coleman, Jonathan ^a   Dalbagni, Guido ^a   Touijer, Karim ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinoma; kidney neoplasms; mortality; nephrectomy; renal cell; treatment outcome

Indexed keywords

ADULT; AGED; ARTICLE; ASYNCHRONOUS METASTASIS; CANCER RISK; CANCER SIZE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SYNCHRONOUS METASTASIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; NEW YORK CITY; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 67349202279     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.128     Document Type: Article

References (19)

1. Herrlinger A., Schott G., Schafhauser W., and Schrott K.M. The significance of tumor diameter in renal cell carcinoma. Urologe A 31 (1992) 70
2. Miller J., Fischer C., Freese R., Altmannsberger M., and Weidner W. Nephron-sparing surgery for renal cell carcinoma-is tumor size a suitable parameter for indication?. Urology 54 (1999) 988
3. Remzi M., Ozsoy M., Klingler H.C., Susani M., Waldert M., Seitz C., et al. Are small renal tumors harmless?. Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176 (2006) 896
4. Wunderlich H., Reichelt O., Schumann S., Schlichter A., Kosmehl H., Werner W., et al. Nephron sparing surgery for renal cell carcinoma 4 cm. or less in diameter: indicated or under treated?. J Urol 159 (1998) 1465
5. Duffey B.G., Choyke P.L., Glenn G., Grubb R.L., Venzon D., Linehan W.M., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172 (2004) 63
6. Kunkle D.A., Crispen P.L., Li T., and Uzzo R.G. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol 177 (2007) 1692
7. Klatte T., Patard J.J., de Martino M., Bensalah K., Verhoest G., de laTaille A., et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 179 (2008) 1719
8. Abouassaly R., Lane B.R., and Novick A.C. Active surveillance of renal masses in elderly patients. J Urol 180 (2008) 505
9. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.L., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer Press, New York
10. Frank I., Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., and Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173 (2005) 1889
11. Leibovich B.C., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171 (2004) 1066
12. Dash A., Vickers A.J., Schachter L.R., Bach A.M., Snyder M.E., and Russo P. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int 97 (2006) 939
13. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395
14. Raj G.V., Thompson R.H., Leibovich B.C., Blute M.L., Russo P., and Kattan M.W. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179 (2008) 2146
15. Sorbellini M., Kattan M.W., Snyder M.E., Reuter V., Motzer R., Goetzl M., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48
16. Ficarra V., Martignoni G., Lohse C., Novara G., Pea M., Cavalleri S., et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 175 (2006) 1235
17. Fujii Y., Saito K., Iimura Y., Sakai Y., Koga F., Kawakami S., et al. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. J Urol 180 (2008) 1290
18. Chawla S.N., Crispen P.L., Hanlon A.L., Greenberg R.E., Chen D.Y., and Uzzo R.G. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425
19. Crispen P.L., Viterbo R., Fox E.B., Greenberg R.E., Chen D.Y., and Uzzo R.G. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112 (2008) 1051